Home Cart Sign in  
Chemical Structure| 2370013-12-8 Chemical Structure| 2370013-12-8

Structure of Sunvozertinib
CAS No.: 2370013-12-8

Chemical Structure| 2370013-12-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sunvozertinib is a potent inhibitor of ErbBs (EGFR, Her2) and BTK, especially effective against various EGFR mutants (including EGFR L858R and T790M mutations). It is suitable for research and treatment of EGFR and Her2 mutant cancers.

Synonyms: DZD9008

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sunvozertinib

CAS No. :2370013-12-8
Formula : C29H35ClFN7O3
M.W : 584.08
SMILES Code : C=CC(NC1=CC(NC2=NC=CC(NC3=CC(Cl)=C(F)C=C3C(C)(O)C)=N2)=C(OC)C=C1N4C[C@H](N(C)C)CC4)=O
Synonyms :
DZD9008
MDL No. :MFCD34567621

Safety of Sunvozertinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Sunvozertinib

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03974022 Non-Small Cell Lung Cancer PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 2025-07-25 University of California, San ... More >>Diego (UCSD) - Moores Cancer Center, La Jolla, California, 92093, United States|University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|Innovative Clinical Research Institute, LLC, Whittier, California, 90603-2137, United States|University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Michigan Center of Medical Research, Farmington Hills, Michigan, 48334, United States|Northwell Health - Centers for Advanced Medicine, New Hyde Park, New York, 11042-1118, United States|Laura and Isaac Perlmutter Cancer Center, New York, New York, 10016, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210-1240, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Fundacion Respirar - Consultorios Medicos Dr. Doreski, Cabildo, Argentina|CEMIC Centro de Educación Médica e Investigaciones Clínicas - Hospital Universitario sede Saavedra, Ciudad Autónoma Buenos Aires, Argentina|Centro Medico Austral OMI, Ciudad Autónoma Buenos Aires, Argentina|Diabaid, Ciudad Autónoma Buenos Aires, Argentina|Fundacion CENIT Para La Investigacion en Neurociencias, Ciudad Autónoma Buenos Aires, Argentina|Instituto Argentino de Diagnositco y Tratamiento S.A., Ciudad Autónoma Buenos Aires, Argentina|Instituto Medico de la Fundacion de Estudios Clínicos, Ciudad Autónoma Buenos Aires, Argentina|Centro de Investigación Pergamino SA, Pergamino, Argentina|Clinica Viedma S.A, Viedma, Argentina|Blacktown Hospital, Blacktown, Australia|Chris O'Brien Lifehouse, Camperdown, Australia|Austin Hospital, Heidelberg, Australia|St George Hospital, Kogarah, Australia|Peter MacCallum Cancer Centre - East Melbourne, North Melbourne, Australia|Linear Cancer trials, Perth, Australia|Southern Medical Day Care Centre, Wollongong, Australia|Princess Margaret Cancer Centre, Toronto, Canada|Fundación Arturo López Pérez, Providencia, Chile|Orlandi Oncología - Centro Médico Health & Care, Santiago, Chile|SAGA, Santiago, Chile|James Lind Centro De Investigacion Del Cancer, Temuco, Chile|Beijing Cancer Hospital, Beijing, China|Beijing Chest Hospital,Capital Medical University, Beijing, China|Peking Union Medical College Hospital, Beijing, China|Jilin Cancer Hospital, Changchun, China|Hunan Cancer Hospital, Changsha, China|West China Hospital of Sichuan University, Chengdu, China|Chongqing Cancer Hospital, Chongqing, China|Fujian Cancer Hospital, Fuzhou, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China|Hainan General Hospital, Haikou, China|The First Affilated Hospital of Zhejiang University, Hangzhou, China|Zhejiang Cancer Hospital, Hangzhou, China|Harbin Medical University Cancer Hospital, Harbin, China|The first Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei, China|The Second Hospital of Anhui Medical University, Hefei, China|Henan Cancer Hospital, Henan, China|The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China|The Affiliated Huaian No.1 Peoples Hospital of Nanjing Medical University, Huai'an, China|Jinan Central Hospital, Jinan, China|Linyi Cancer Hospital, Linyi, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|The Second Affiliated Hospital of Nanchang University, Nanchang, China|Guangxi Medical University Cancer Hospital, Nanning, China|Zhongshan Hospital, Fudan University, Shanghai, China|The First Hospital of China Medical University, Shenyang, China|Shanxi Cancer Hospital, Taiyuan, China|Taizhou Hospital of Zhejiang Province, Taizhou, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|Hubei Cancer Hospital, Wuhan, China|Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China|Centre Hospitalier Universitaire d'Angers, Angers, France|Hospices Civils de Lyon - H?pital Louis Pradel, Bron, France|Centre Georges Fran?ois Leclerc, Dijon, France|CHU de Lille - Institut Coeur Poumons, Hellemmes Lille, France|H?pital de La Timone AP-Hm, Marseille, France|CHU de Montpellier H?pital Arnaud de Villeneuve, Montpellier, France|APHP-H?pital Bichat - Claude Bernard, Paris, France|CHU de Poitiers, Poitiers, France|Institut de Cancérologie de l'Ouest, Saint-Herblain, France|HIA Begin, Saint-Mandé, France|CHU de Toulouse - H?pital Larrey, Toulouse, France|Institut Gustave ROUSSY, Villejuif, France|Centro di Riferimento Oncologico (CRO), Aviano, Italy|Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele", Catania, Italy|Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS, Meldola, Italy|Istituto Europeo di Oncologia, Milano, Italy|Azienda Ospedaliero-Universitaria di Parma, Parma, Italy|AUSL Romagna - Ospedale S.M delle Croci, Ravenna, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|Istituti Fisioterapici Ospitalieri, Roma, Italy|National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Japan|Aichi Cancer Center Hospital, Nagoya-Shi, Japan|Niigata University Medical & Dental Hospital, Niigata-Shi, Japan|Okayama University Hospital, Okayama-Shi, Japan|Tokushima University Hospital, Tokushima-Shi, Japan|Tokyo Shinagawa Hospital, Tokyo, Japan|Chungbuk National University Hospital, Cheonju, Korea, Republic of|National Cancer Center, Goyang, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon, Korea, Republic of|Hospital Sultan Ismail, Johor Bahru, Malaysia|Hospital Kuala Lumpur, Kuala Lumpur, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Vall d'Hebrón, Barcelona, Spain|ICO (Institut Catala d'Oncologia) Badalona - Hospital Germans Trias i Pujol, Barcelona, Spain|Institut Català d'Oncología de Girona - Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain|Hospital de Jeréz, Jerez de la Frontera, Spain|Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain|Clínica Universidad de Navarra, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Regional Universitario de Malaga, Malaga, Spain|Hospital Universitario Virgen de Valme, Sevilla, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital La Fe, Valencia, Spain|Chi Mei Hospital, Liouying, Liuying, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Wan Fang Hospital, Taipei, Taiwan|Chang Gung Memorial Hospital, Taoyuan, Taiwan Less <<
NCT05712902 Non-Small Cell Lung Cancer PHASE2 ACTIVE_NOT_RECRUITING 2025-12-31 Beijing Cancer Hospital, Beiji... More >>ng, China|Beijing Chest Hospital,Capital Medical University, Beijing, China|Peking Union Medical College Hospital, Beijing, China|Peking University Third Hospital, Beijing, China|Jilin Cancer Hospital, Chang chun, China|Hunan Cancer Hospital(The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China|West China Hospital of Sichuan University, Chengdu, China|Army Medical Center of PLA, Chongqing, China|Chongqing University Cancer Hospital(Chongqing Cancer Hospital), Chongqing, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China|Hainan General Hospital, Haikou, China|The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China|The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China|Zhejiang Cancer Hospital (Cancer Hospital of the University of Chinese Academy of Sciences), Hangzhou, China|Harbin Medical University Cancer Hospital, Harbin, China|The Second Hospital of Anhui Medical University, Hefei, China|The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China|Jinan Central Hospital (Central Hospital Affiliated to Shandong First Medical University), Jinan, China|Yunnan Cancer Hospital, Kunming, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|The Second Affiliated Hospital of Nanchang University, Nanchang, China|Fudan University Shanghai Cancer Center, Shanghai, China|The First Hospital of China Medical University, Shenyang, China|The Fourth Hospital of Hebei Medical University, Shijiazhuang, China|The First Affiliated Hospital of Soochow University, Suzhou, China|Shanxi Provincial Cancer Hospital, Taiyuan, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|Hubei Cancer Hospital, Wuhan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China|Affiliated Cancer Hospital of Zhengzhou University(Henan Cancer Hospital), Zhengzhou, China|The Affiliated Cancer Hospital of Xinjiang Medical University, ürümqi, China Less <<
NCT06786208 Non Small Cell Lung Cancer NOT_YET_RECRUITING 2027-06-30 Qiming Wang, Zhengzhou, Henan,... More >> 450000, China Less <<
NCT04148742 Non-Hodgkin's B-cell Lymphoma PHASE1|PHASE2 SUSPENDED 2025-07-23 Institute of Hematology & Bloo... More >>d Diseases Hospital, Chinese Academy of Medical Sciences, Nanjing, China|Jiangsu Province Hospital - Haematology, Nanjing, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.71mL

0.34mL

0.17mL

8.56mL

1.71mL

0.86mL

17.12mL

3.42mL

1.71mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories